Dr. Thomas Schwarz from the Boston Children’ Hospital and Harvard Medical School is describing in a short video the role of neurons and defect mitochondria in ARSACS.
An international network of ARSACS centers is conducting a multi-center study to collect natural history data and biomarkers, essential data to initiate treatment for ARSACS. We encourage you in joining in these studies and thus supporting the preparation of future treatment trials.
As an ARSACS patient, all you need to do is an outpatient visit at one of the participating centers for a a blood test (Study #1 ) and MRI and blood sampling in the case of the more advanced study (Study #2 conducted only in centers in Quebec and Germany).
Furthermore, Dr. Matthis Synofzik from University of Tubingen, Germany explains why ARSACS patients’ participation is very important in the development of a treatment.
Research project presentation by Dr. Fabiana Longo who is working with Dr. Maltecca.
Dr. Cynthia Gagnon will undertake a pilot project entitled “Un meilleur contrôle du tronc et des membres inférieurs pour une meilleure mobilité: Évaluation d’un programme de réentraînement pour les personnes atteintes de l’ARSACS”. This pilot project aims to document the effects of a retraining program to increase the motor control of the trunk and lower limbs.
Dr. Francesca Maltecca is giving an overview of her research project.
Dr. Strack from Unversity of Iowa (US) provides a short description of his ARSACS research project.
Congratulations! Dr. Cynthia Gagnon has received the “Researcher of the Year” national award given by Muscular Dystrophy Canada.
Dr. Gagnon is a member of the ARSACS research team. Article published in the Quotidien on Wednesday, November 28, 2018. (Article in French only).
As part of the video serie, Dr. Brais provides an overview of the ARSACS research projects.
The music was “Whisps of Whorles” by Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License
Camera and Edit by Anthony Revoy of Neuro Media Services
“Screening of the Pfizer Chemo-Genetics 3000 compound library for ARSACS” – a new research project to be undertaken shortly at the Children’s Hospital of Eastern Ontario in Ottawa. Stay tuned!
In an effort to make research easier to understand, the ARSACS researchers have produced a serie of short videos describing their respective project. The first one is a presentation by Dr.Ghering.
If you or a family member has received an ARSACS diagnostic, you are invited to register. It is easy and simple.
The registry is available in 4 languages English, French Spanish and in Italian. This is a way for you to support the cause.
The Structural Genomics Consortium in Frankfurt will be sending shortly some molecules to the Institute for Research in Immunology and Cancer of the University of Montreal. These molecules will be tested on ARSACS.
Thanks to your generosity, the Foundation can continue to fund research on ARSACS with the aim of developing a treatment for this rare disease. Special thanks to the co-chairs Mrs. Erin Slater Battat and Mr.Joe Battat, chefs, sponsors,donors and all the volunteers. This would not have been possible without you.
About 50 world expert researchers on ARSACS shared their data and knowledge at the International ARSACS Symposium hosted by the Neuro in Montreal.
Dr. Brais, Neuro’s leading expert on ARSACS, describes why this is an important conference.